Colin Walsh


Colin Walsh, Ph.D. is a partner at Qiming Venture Partners USA. He currently serves on the board of Korro Bio and Elevation Oncology and is a board observer of Amphivena Therapeutics and Icosavax.

Before joining Qiming in 2019, Colin was a vice president on the life science investment team at ND Capital where he sourced, structured and managed ...

Roles at Korro Bio

  • Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.